Cover Image

The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant <em>Klebsiella pneumoniae</em> Isolates

Carbapenem-resistant Enterobacteriaceae (CRE), especially carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP), are among the largest pathogenic threats to humans. The available antibiotic treatment options for combating CRKP are limited. Colistin-resistant Enterobacteriaceae (CoRE)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Parnrada Nulsopapon (Author), Worapong Nasomsong (Author), Manat Pongchaidecha (Author), Dhitiwat Changpradub (Author), Piraporn Juntanawiwat (Author), Wichai Santimaleeworagun (Author)
Format:	Book
Published:	MDPI AG, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correction: Nulsopapon et al. The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Isolates. <i>Antibiotics</i> 2021, <i>10</i>, 736
by: Parnrada Nulsopapon, et al.
Published: (2022)

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Worapong Nasomsong, et al.
Published: (2022)

Antimicrobial Activity Profiles and Potential Antimicrobial Regimens against Carbapenem-Resistant Enterobacterales Isolated from Multi-Centers in Western Thailand
by: Parnrada Nulsopapon, et al.
Published: (2022)

The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital
by: Nasomsong W, et al.
Published: (2021)

Evaluation of the synergistic effect of eravacycline and tigecycline against carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae
by: Yu-Shan Huang, et al.
Published: (2024)

Effectiveness and resource utilization of hospital-based contact tracing of patients and health care workers with COVID-19 at a tertiary teaching hospital in Thailand
by: Worapong Nasomsong, et al.
Published: (2023)

Clinical Impact of Vancomycin Treatment in Ampicillin-Susceptible Enterococci Bloodstream Infections
by: Jatapat Hemapanpairoa, et al.
Published: (2022)

Does Vancomycin Resistance Increase Mortality? Clinical Outcomes and Predictive Factors for Mortality in Patients with <i>Enterococcus faecium</i> Infections
by: Jatapat Hemapanpairoa, et al.
Published: (2021)

Activity of carbapenems and tigecycline against ESBL-producing Escherichia coli and Klebsiella spp.
by: Caio Fernando de Oliveira, et al.
Published: (2018)

Proteomic analysis of carbapenem-resistant Klebsiella pneumoniae outer membrane vesicles under the action of phages combined with tigecycline
by: Jing Mao, et al.
Published: (2024)

Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> Infections
by: Thanawat Chattaweelarp, et al.
Published: (2020)

Carbapenem-Resistant <em>Klebsiella pneumoniae</em> Associated with COVID-19
by: Irina Magdalena Dumitru, et al.
Published: (2021)

Susceptibility of Tigecycline against Carbapenem Resistant Enterobacteriaceae
by: Madeeha Fatima, et al.
Published: (2024)

Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19
by: Samaneh Pourajam, et al.
Published: (2023)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023)

Impact of Tigecycline's MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy-Validation of 2019's EUCAST Proposed Breakpoint Changes
by: Matthaios Papadimitriou-Olivgeris, et al.
Published: (2020)

Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>: A Propensity Score-Matched Cohort Study
by: Lei Zha, et al.
Published: (2023)

Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant <i>Klebsiella pneumoniae</i> Pneumonia-Septicemia Model in Rats
by: Hessel Van der Weide, et al.
Published: (2020)

Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae
by: Juan Yi, et al.
Published: (2023)

Detection of Carbapenem-Resistant Klebsiella pneumonia using two Sensitivity Methods
by: Ghusoon Ali Abdulhasan, et al.
Published: (2015)

Genomic analysis of the emerging carbapenem-resistant Klebsiella pneumoniae sequence type 11 harbouring Klebsiella pneumoniae carbapenemase (KPC) in Oman
by: Mohammed Al Balushi, et al.
Published: (2022)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Pneumonia: An Interim Analysis
by: Chutchawan Ungthammakhun, et al.
Published: (2022)

<it>In vitro </it>activity of tigecycline and comparators against carbapenem-susceptible and resistant <it>Acinetobacter baumannii </it>clinical isolates in Italy
by: Carattoli Alessandra, et al.
Published: (2008)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021)

ANTIBIOTIC COMBINATIONS WITH COLISTIN AGAINST CARBAPENEM-RESISTANT Klebsiella pneumoniae - in vitro ASSESSMENT
by: Yuliya Marteva-Proevska, et al.
Published: (2018)

Clonal complexes of carbapenem-resistant Klebsiella pneumoniae recovered from community sewage
by: Pâmela Maria Oliveira, et al.
Published: (2023)

Characterization of resistance genes and replicon typing in Carbapenem-resistant Klebsiella pneumoniae strains
by: Esin Karaman, et al.
Published: (2024)

Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Strains: A Challenge for Tertiary Care Hospitals
by: Aamir Jamal Gondal, et al.
Published: (2024)

Efficacies of Colistin-Carbapenem versus Colistin-Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
by: Sheng-Huei Wang, et al.
Published: (2021)

Effective treatment of ventriculitis with OXA-48 carbapenem-resistant Klebseilla Pneumonia, followed by bacteremia with NDM carbapenem-resistant Klebsiella Pneumonia-case report
by: F. Mehdawi, et al.
Published: (2020)

Heterogeneity of colistin resistance mechanism in clonal populations of carbapenem-resistant Klebsiella pneumoniae in Vietnam
by: Bui Tien Sy, et al.
Published: (2024)

Hypervirulent carbapenem-resistant Klebsiella pneumoniae causing highly fatal meningitis in southeastern China
by: Na Huang, et al.
Published: (2022)

Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant Klebsiella pneumoniae
by: Wesam H. Abdulaal, et al.
Published: (2024)

Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in COVID-19 Era-Challenges and Solutions
by: Jozef Ficik, et al.
Published: (2023)

Disinfection Strategies for Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in a Healthcare Facility
by: Lijia Ni, et al.
Published: (2022)

Development of prediction models for carbapenem-resistant Klebsiella pneumoniae acquisition and prognosis in adult patients
by: Huijuan Yao, et al.
Published: (2024)

Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
by: Liangfei Xu, et al.
Published: (2017)

Synergistic Inhibition of MRSA by Chenodeoxycholic Acid and Carbapenem Antibiotics
by: Kaiyu Cui, et al.
Published: (2022)

Carbapenem and colistin-resistant hypervirulent Klebsiella pneumoniae: An emerging threat transcending the egyptian food chain
by: Rana Fahmi Sabala, et al.
Published: (2024)